β-lactam resistance and Enterobacteriaceae, United States

Jean M. Whichard, Kevin Joyce, Paul D Fey, Jennifer M. Nelson, Frederick J. Angulo, Timothy J. Barrett

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Extended-spectrum cephalosporins (ESC) are an important drug class for treating severe Salmonella infections. We screened the human collection from the National Antimicrobial Resistance Monitoring System 2000 for ESC resistance mechanisms. Of non-Typhi Salmonella tested, 3.2% (44/1,378) contained bla CMY genes. Novel findings included blaCMY-positive Escherichia coli O157:H7 and a blaCMY-positive Salmonella isolate. CMY-positive isolates showed a ceftriaxone MIC ≥2 μg/mL.

Original languageEnglish (US)
Pages (from-to)1464-1466
Number of pages3
JournalEmerging infectious diseases
Volume11
Issue number9
StatePublished - Sep 1 2005

Fingerprint

Lactams
Enterobacteriaceae
Salmonella
Cephalosporin Resistance
Escherichia coli O157
Ceftriaxone
Salmonella Infections
Cephalosporins
Pharmaceutical Preparations
Genes

ASJC Scopus subject areas

  • Epidemiology
  • Microbiology (medical)
  • Infectious Diseases

Cite this

Whichard, J. M., Joyce, K., Fey, P. D., Nelson, J. M., Angulo, F. J., & Barrett, T. J. (2005). β-lactam resistance and Enterobacteriaceae, United States. Emerging infectious diseases, 11(9), 1464-1466.

β-lactam resistance and Enterobacteriaceae, United States. / Whichard, Jean M.; Joyce, Kevin; Fey, Paul D; Nelson, Jennifer M.; Angulo, Frederick J.; Barrett, Timothy J.

In: Emerging infectious diseases, Vol. 11, No. 9, 01.09.2005, p. 1464-1466.

Research output: Contribution to journalArticle

Whichard, JM, Joyce, K, Fey, PD, Nelson, JM, Angulo, FJ & Barrett, TJ 2005, 'β-lactam resistance and Enterobacteriaceae, United States', Emerging infectious diseases, vol. 11, no. 9, pp. 1464-1466.
Whichard JM, Joyce K, Fey PD, Nelson JM, Angulo FJ, Barrett TJ. β-lactam resistance and Enterobacteriaceae, United States. Emerging infectious diseases. 2005 Sep 1;11(9):1464-1466.
Whichard, Jean M. ; Joyce, Kevin ; Fey, Paul D ; Nelson, Jennifer M. ; Angulo, Frederick J. ; Barrett, Timothy J. / β-lactam resistance and Enterobacteriaceae, United States. In: Emerging infectious diseases. 2005 ; Vol. 11, No. 9. pp. 1464-1466.
@article{1780f069f416479e99cebd5e9e7540a3,
title = "β-lactam resistance and Enterobacteriaceae, United States",
abstract = "Extended-spectrum cephalosporins (ESC) are an important drug class for treating severe Salmonella infections. We screened the human collection from the National Antimicrobial Resistance Monitoring System 2000 for ESC resistance mechanisms. Of non-Typhi Salmonella tested, 3.2{\%} (44/1,378) contained bla CMY genes. Novel findings included blaCMY-positive Escherichia coli O157:H7 and a blaCMY-positive Salmonella isolate. CMY-positive isolates showed a ceftriaxone MIC ≥2 μg/mL.",
author = "Whichard, {Jean M.} and Kevin Joyce and Fey, {Paul D} and Nelson, {Jennifer M.} and Angulo, {Frederick J.} and Barrett, {Timothy J.}",
year = "2005",
month = "9",
day = "1",
language = "English (US)",
volume = "11",
pages = "1464--1466",
journal = "Emerging Infectious Diseases",
issn = "1080-6040",
publisher = "Centers for Disease Control and Prevention (CDC)",
number = "9",

}

TY - JOUR

T1 - β-lactam resistance and Enterobacteriaceae, United States

AU - Whichard, Jean M.

AU - Joyce, Kevin

AU - Fey, Paul D

AU - Nelson, Jennifer M.

AU - Angulo, Frederick J.

AU - Barrett, Timothy J.

PY - 2005/9/1

Y1 - 2005/9/1

N2 - Extended-spectrum cephalosporins (ESC) are an important drug class for treating severe Salmonella infections. We screened the human collection from the National Antimicrobial Resistance Monitoring System 2000 for ESC resistance mechanisms. Of non-Typhi Salmonella tested, 3.2% (44/1,378) contained bla CMY genes. Novel findings included blaCMY-positive Escherichia coli O157:H7 and a blaCMY-positive Salmonella isolate. CMY-positive isolates showed a ceftriaxone MIC ≥2 μg/mL.

AB - Extended-spectrum cephalosporins (ESC) are an important drug class for treating severe Salmonella infections. We screened the human collection from the National Antimicrobial Resistance Monitoring System 2000 for ESC resistance mechanisms. Of non-Typhi Salmonella tested, 3.2% (44/1,378) contained bla CMY genes. Novel findings included blaCMY-positive Escherichia coli O157:H7 and a blaCMY-positive Salmonella isolate. CMY-positive isolates showed a ceftriaxone MIC ≥2 μg/mL.

UR - http://www.scopus.com/inward/record.url?scp=23944466872&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23944466872&partnerID=8YFLogxK

M3 - Article

C2 - 16229784

AN - SCOPUS:23944466872

VL - 11

SP - 1464

EP - 1466

JO - Emerging Infectious Diseases

JF - Emerging Infectious Diseases

SN - 1080-6040

IS - 9

ER -